This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Vertex already has generated billions of dollars in earnings from its cystic fibrosis portfolio....…
432,100€
0,68%
Echtzeit-Aktienkurs Vertex Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Vertex Pharmaceuticals Inc. Aktie
Insiderhandel: EVP, Cell & Genetic Therapies verkauft Aktien von Vertex Pharmaceuticals im Wert von 147.713$
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-05-05...…
Insiderhandel: Executive Chairman verkauft Aktien von Vertex Pharmaceuticals im Wert von 392.625$
Leiden, Jeffrey M. - Vorstand - Tag der Transaktion: 2023-05-08...…
Insiderhandel: EVP, Cell & Genetic Therapies verkauft Aktien von Vertex Pharmaceuticals im Wert von 997.500$
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-05-08...…
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock
Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a…
Insiderhandel: Executive Chairman verkauft Aktien von Vertex Pharmaceuticals im Wert von 1.578.301$
Leiden, Jeffrey M. - Vorstand - Tag der Transaktion: 2023-05-03...…
Insiderhandel: EVP, Cell & Genetic Therapies verkauft Aktien von Vertex Pharmaceuticals im Wert von 975.418$
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-05-03...…
Insiderhandel: EVP, Cell & Genetic Therapies verkauft Aktien von Vertex Pharmaceuticals im Wert von 568.769$
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-05-02...…
Insiderhandel: Executive Chairman verkauft Aktien von Vertex Pharmaceuticals im Wert von 2.256.761$
Leiden, Jeffrey M. - Vorstand - Tag der Transaktion: 2023-05-02...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Vertex Pharmaceuticals im Wert von 202.005$
Bhatia, Sangeeta N. - Aufsichtsrat - Tag der Transaktion: 2023-05-02...…
7 Reasons to Buy Vertex Pharmaceuticals Stock Now
Its not too late to invest in this top biotech stock....…
Form 10-Q VERTEX PHARMACEUTICALS For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Vertex dominates the cystic fibrosis market today....…
Vertex (VRTX) Q1 Earnings Top Estimates, Revenues Up Y/Y
Vertex Pharmaceuticals (VRTX) first-quarter 2023 earnings and sales beat estimates. Management reiterates financial guidance for 2023....…
Vortex beauftragt Independent Trading Group als Market Maker
2. Mai 2023 - Vancouver, British Columbia / IRW-Press / - Vortex Energy Corp. (CSE: VRTX | OTC: VTECF |…
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie
One big drugmakers pain translates into another big drugmakers gain....…
Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2023....…
Insiderhandel: CEO & President verkauft Aktien von Vertex Pharmaceuticals im Wert von 1.124.726$
Kewalramani, Reshma - Vorstand - Tag der Transaktion: 2023-04-27...…
Vertex Pharmaceuticals Inc. Q1 Profit Decreases, but beats estimates
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) released earnings for first quarter that decreased from the same period last…
Strength Seen in Vertex (VRTX): Can Its 5.0% Jump Turn into More Strength?
Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…
Vertex Pharmaceuticals (VRTX) Stock Moves -0.27%: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $331.93, marking a -0.27% move from the previous day....…
The Zacks Analyst Blog Highlights Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCI
Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCI are included in this Analyst Blog....…
Top Stock Reports for Linde, Vertex Pharmaceuticals & Edwards Lifesciences
Todays Research Daily features new research reports on 16 major stocks, including Linde plc (LIN), Vertex Pharmaceuticals Incorporated (VRTX) and…
Why Vertex (VRTX) Could Beat Earnings Estimates Again
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Insiderhandel: EVP, Cell & Genetic Therapies verkauft Aktien von Vertex Pharmaceuticals im Wert von 2.472.165$
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-04-12...…
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $326.37, marking a +0.47% move from the previous day....…
Insiderhandel: EVP, Cell & Genetic Therapies verkauft Aktien von Vertex Pharmaceuticals im Wert von 164.853$
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-04-04...…
Is Vertex (VRTX) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Vertex (VRTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…
The Zacks Analyst Blog Highlights bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals
bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals are included in this Analyst Blog....…
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $316.33, marking a +0.4% move from the previous day....…
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
These stocks look reasonably priced considering their future prospects....…
Insiderhandel: EVP & Chief Financial Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 539.912$
Wagner, Charles F Jr - Vorstand - Tag der Transaktion: 2023-03-24...…
Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug
Vertex Therapeutics (VRTX) enters into a licensing agreement with CRISPR for the latters gene-editing technology to accelerate the development of…
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $308.47, marking a -1.88% move from the previous day....…
10 Analysts Have This to Say About Vertex Pharmaceuticals
Latest Ratings for VRTX
DateFirmActionFromTo Feb 2022RBC CapitalDowngradesOutperformSector Perform Jan 2022BMO CapitalUpgradesMarket PerformOutperform Dec 2021Wells FargoInitiates Coverage OnOverweight
…
Insiderhandel: EVP, Cell & Genetic Therapies verkauft Aktien von Vertex Pharmaceuticals im Wert von 825.422$
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-03-16...…
Vortex Energy Corp. meldet Ernennung von Paul Sparkes zum Chief Executive Officer und Director
20. März 2023. Vancouver, British Columbia / IRW-Press / Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FWB: AA3)…
Brokers Suggest Investing in Vertex (VRTX): Read This Before Placing a Bet
According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after…
Vortex Energy Corp. Announces Appointment of Paul Sparkes as Chief Executive Officer & Director
VANCOUVER, British Columbia, March 20, 2023 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX | OTC: VTECF |…
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $295.77, moving -1.62% from the previous trading session....…
Insiderhandel: EVP & Chief Financial Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 783.346$
Wagner, Charles F Jr - Vorstand - Tag der Transaktion: 2023-03-13...…
Insiderhandel: EVP & Chief Financial Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 604.708$
Wagner, Charles F Jr - Vorstand - Tag der Transaktion: 2023-03-10...…
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $287.24, marking a +0.13% move from the previous day....…
Vertex (VRTX) to Begin Clinical Study on Type I Diabetes Drug
Vertex Pharmaceuticals (VRTX) receives FDA clearance to begin clinical development of VX-264, which has the potential to treat type I…
Vertex (VRTX) Down 2.8% Since Last Earnings Report: Can It Rebound?
Vertex (VRTX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…
Vertex Pharma: FDA Clears IND Application For VX-264; Plans To Begin Phase 1/2 Trial In H1
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Incorporated (VRTX) announced the FDA has cleared the Investigational New Drug Application for VX-264,…
ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing
read more...…
Insiderhandel: EVP, Chief Reg. & Quality Off. verkauft Aktien von Vertex Pharmaceuticals im Wert von 101.769$
Tatsis, Ourania - Vorstand - Tag der Transaktion: 2023-02-27...…
Insiderhandel: EVP, COO verkauft Aktien von Vertex Pharmaceuticals im Wert von 706.679$
Arbuckle, Stuart A. - Vorstand - Tag der Transaktion: 2023-02-22...…
Insiderhandel: EVP, Global Research and CSO verkauft Aktien von Vertex Pharmaceuticals im Wert von 1.175.675$
Altshuler, David - Vorstand - Tag der Transaktion: 2023-02-21...…